510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

UroLift System (UL400)

K193269510(k) SpecialCleared Dec 20, 201924-day reviewClass II21 CFR 876.5530Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Neotract, Inc. · PEW Implantable Transprostatic Tissue Retractor System

Cleared on Dec 20, 2019 as substantially equivalent to K173087 (Neotract, Inc., 2017) after a 24-day review. Its family tree reaches back 6 generations to 2013. 1 later device descends from it. It has been recalled once.

Decided
Dec 20, 2019
Review
24 days
Class
Class II
Product code
PEW
Recalls
1
Predicates
1

Its longest line of descent runs back 6 generations to DEN130023 (2013). 1 later device descends from it, 1 citing it directly.

  1. Root · 6 generations backDEN130023 Urolift SystemNeotract, Inc. · 2013
  2. 5 generations backK133281 Neotract Urolift SystemNeotract, Inc. · 2013
  3. 4 generations backK153584 NeoTract UroLift System UL500Neotract, Inc. · 2016
  4. 3 generations backK162345 UroLift System UL500, UroLift Delivery Handle, UroLift Implant…Neotract, Inc. · 2016
  5. 2 generations backK172359 UroLift System (UL500)Neotract, Inc. · 2017
  6. 1 generation backK173087 UroLift System (UL400 and UL500)Neotract, Inc. · 2017 · Recalled
  7. This deviceK193269 UroLift System (UL400)Neotract, Inc. · 2019
  8. Descendant · cites it directly · 0 of its ownK200441 UroLift Advanced Tissue Control (ATC) SystemNeotract, Inc. · 2020

Most influential descendants

Showing 1 of 1 · See all
  • K200441UroLift Advanced Tissue Control (ATC) SystemNeotract, Inc. · 2020 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6DEN130023Urolift SystemNeotract, Inc.2013—
−5K133281Neotract Urolift SystemNeotract, Inc.2013—
−4K153584NeoTract UroLift System UL500Neotract, Inc.2016—
−3K162345UroLift System UL500, UroLift Delivery Handle, UroLift Implant CartiridgeNeotract, Inc.2016—
−2K172359UroLift System (UL500)Neotract, Inc.2017—
−1K173087UroLift System (UL400 and UL500)Neotract, Inc.20171
0 (this device)K193269UroLift System (UL400)Neotract, Inc.2019—
+1K200441UroLift Advanced Tissue Control (ATC) SystemNeotract, Inc.2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
FIG. 1 — Lineage of K193269, 2013–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PEW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PEW device

  1. #1 K232558 UroLift 2 ATC Advanced Tissue Control Systemscore 7.9 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K173087UroLift System (UL400 and UL500)
Summary page 4
…tissue of the prostate with the UroLift Implant. The procedure typically requires 2-6 implants to retract the obstruction. The UL400 (most recently cleared in K173087), consists of two main components, the UroLift Delivery Device (single use), and the UroLift Implants (one implant per deliv…
Neotract, Inc.20171

Also cleared against K173087: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K200441UroLift Advanced Tissue Control (ATC) SystemNeotract, Inc.20200

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 24, 2022Class IIZ-1502-2022Under Investigation by firmThere is the potential that during implant deployment, the device may not properly deliver a implant.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 1 company; a new generation was cleared every 11 months on median.
  • 1 of the 6 ancestors has a recall of any class.
  • Of its descendants, K200441 (Neotract, Inc., 2020) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K173087.

How does its category compare?

All PEW devices

PEW Implantable Transprostatic Tissue Retractor System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · PEW

1in 2023

2013: 22016: 22017: 22019: 22020: 22023: 1
2007high 2 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PEW

Too few PEW 510(k)s in any year since 2007 to give a median.

Recalls per year · PEW

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PEW

69in 2025

2013: 12015: 62016: 82017: 82018: 172019: 472020: 652021: 502022: 552023: 522024: 372025: 69
2007high 69 (2025) · low 0 (2007)2025

MAUDE reports naming product code PEW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20132—01
20140—00
20150—06
20162—08
20172—08
20180—117
20192—047
20202—065
20210—050
20220—055
20231—052
20240—037
20250—069
20260—0—

What is it indicated for?

The UroLift System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH), including lateral and median lobe hyperplasia, in men 45 years of age or older.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K193269: UroLift System (UL400).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K193269

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026